🇺🇸 Glycopyrronium 2.4 % Medicated Cloth in United States

FDA authorised Glycopyrronium 2.4 % Medicated Cloth on 28 June 2018

Marketing authorisation

FDA — authorised 28 June 2018

  • Application: NDA210361
  • Marketing authorisation holder: JOURNEY
  • Local brand name: QBREXZA
  • Indication: CLOTH — TOPICAL
  • Status: approved

Read official source →

Frequently asked questions

Is Glycopyrronium 2.4 % Medicated Cloth approved in United States?

Yes. FDA authorised it on 28 June 2018.

Who is the marketing authorisation holder for Glycopyrronium 2.4 % Medicated Cloth in United States?

JOURNEY holds the US marketing authorisation.